{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:33:39Z","timestamp":1779910419337,"version":"3.53.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402333"],"award-info":[{"award-number":["82402333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171987"],"award-info":[{"award-number":["82171987"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272043"],"award-info":[{"award-number":["82272043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic science project of the educational department of Liaoning province","award":["LJ232410159018"],"award-info":[{"award-number":["LJ232410159018"]}]},{"name":"Liaoning Provincial Science and Technology Program Joint Plan Project","award":["2024-MSLH-547"],"award-info":[{"award-number":["2024-MSLH-547"]}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC2412076"],"award-info":[{"award-number":["XLYC2412076"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-04040-5","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:17:25Z","timestamp":1772115445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Can FAPI\u2013PET be used to evaluate cardiac fibroblast activation and predict left ventricular function in patients with cardiovascular diseases? A systematic review and meta-analysis"],"prefix":"10.1186","volume":"31","author":[{"given":"Shu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"5","key":"4040_CR1","first-page":"733","volume":"37","author":"KK Teo","year":"2021","unstructured":"Teo KK, Rafiq T. Cardiovascular risk factors and prevention: a perspective from developing countries. Can J Cardiol. 2021;37(5):733\u201343.","journal-title":"Can J Cardiol"},{"key":"4040_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00186","volume":"8","author":"L Fang","year":"2017","unstructured":"Fang L, Murphy AJ, Dart AM. A clinical perspective of anti-fibrotic therapies for cardiovascular disease. Front Pharmacol. 2017;8:186.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4040_CR3","doi-asserted-by":"publisher","first-page":"H655","DOI":"10.1152\/ajpheart.00559.2023","volume":"326","author":"C Dufeys","year":"2024","unstructured":"Dufeys C, Bodart J, Bertrand L, et al. Fibroblasts and platelets: a face-to-face dialogue at the heart of cardiac fibrosis. Am J Physiol Heart Circ Physiol. 2024;326(3):H655\u201369.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"23","key":"4040_CR4","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1136\/heartjnl-2019-315560","volume":"105","author":"R Bing","year":"2019","unstructured":"Bing R, Dweck MR. Myocardial fibrosis: why image, how to image and clinical implications. Heart. 2019;105(23):1832\u201340.","journal-title":"Heart"},{"issue":"5","key":"4040_CR5","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10741-022-10214-0","volume":"27","author":"M Lisi","year":"2022","unstructured":"Lisi M, Cameli M, Mandoli GE, et al. Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications. Heart Fail Rev. 2022;27(5):1857\u201367.","journal-title":"Heart Fail Rev"},{"issue":"11","key":"4040_CR6","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcmg.2016.01.036","volume":"9","author":"S Raina","year":"2016","unstructured":"Raina S, Lensing SY, Nairooz RS, et al. Prognostic value of late\u00a0Gadolinium\u00a0enhancement CMR in\u00a0systemic amyloidosis. JACC Cardiovasc Imaging. 2016;9(11):1267\u201377.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"4040_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s13244-016-0494-5","volume":"7","author":"H Chalian","year":"2016","unstructured":"Chalian H, O\u2019donnell JK, Bolen M, et al. Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities. Insights Imaging. 2016;7(4):485\u2013503.","journal-title":"Insights Imaging"},{"issue":"12","key":"4040_CR8","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.2967\/jnumed.120.242958","volume":"61","author":"J Toms","year":"2020","unstructured":"Toms J, Kogler J, Maschauer S, et al. Targeting fibroblast activation protein: radiosynthesis and preclinical evaluation of an (18)F-labeled FAP inhibitor. J Nucl Med. 2020;61(12):1806\u201313.","journal-title":"J Nucl Med"},{"issue":"4","key":"4040_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF Mcinnes","year":"2018","unstructured":"Mcinnes MDF, Moher D, Thombs BD, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388\u201396.","journal-title":"JAMA"},{"issue":"8","key":"4040_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"3","key":"4040_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s12350-020-02307-w","volume":"28","author":"J Siebermair","year":"2021","unstructured":"Siebermair J, K\u00f6hler MI, Kupusovic J, et al. Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury\/remodeling. J Nucl Cardiol. 2021;28(3):812\u201321.","journal-title":"J Nucl Cardiol"},{"key":"4040_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.921724","volume":"9","author":"Z Lyu","year":"2022","unstructured":"Lyu Z, Han W, Zhao H, et al. A clinical study on relationship between visualization of cardiac fibroblast activation protein activity by Al(18)F-NOTA-FAPI-04 positron emission tomography and cardiovascular disease. Front Cardiovasc Med. 2022;9:921724.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"4040_CR13","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","volume":"63","author":"J Diekmann","year":"2022","unstructured":"Diekmann J, Koenig T, Thackeray JT, et al. Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome. J Nucl Med. 2022;63(9):1415\u201323.","journal-title":"J Nucl Med"},{"issue":"8","key":"4040_CR14","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1007\/s00259-021-05674-9","volume":"49","author":"B Xie","year":"2022","unstructured":"Xie B, Wang J, Xi XY, et al. Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2022;49(8):2786\u201397.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"4040_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00259-022-06015-0","volume":"50","author":"M Zhang","year":"2023","unstructured":"Zhang M, Quan W, Zhu T, et al. [(68)Ga]Ga-DOTA-FAPI-04 PET\/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling. Eur J Nucl Med Mol Imaging. 2023;50(3):839\u201348.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"4040_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/RLU.0000000000003745","volume":"46","author":"L Kessler","year":"2021","unstructured":"Kessler L, Kupusovic J, Ferdinandus J, et al. Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI PET. Clin Nucl Med. 2021;46(10):807\u201313.","journal-title":"Clin Nucl Med"},{"key":"4040_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.614997","volume":"8","author":"D Finke","year":"2021","unstructured":"Finke D, Heckmann MB, Herpel E, et al. Early detection of checkpoint inhibitor-associated myocarditis using (68)Ga-FAPI PET\/CT. Front Cardiovasc Med. 2021;8:614997.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"4040_CR18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00259-022-06081-4","volume":"50","author":"C Treutlein","year":"2023","unstructured":"Treutlein C, Distler JHW, Tascilar K, et al. Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT. Eur J Nucl Med Mol Imaging. 2023;50(6):1629\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"4040_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00259-024-06878-5","volume":"52","author":"J Ding","year":"2024","unstructured":"Ding J, Zhang H, Chen X, et al. Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [(68)Ga]Ga-FAPI-04 PET\/CMR imaging. Eur J Nucl Med Mol Imaging. 2024;52(1):98\u2013108.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"4040_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jcmg.2024.10.001","volume":"18","author":"X Wang","year":"2025","unstructured":"Wang X, Shen K, Zhang Y, et al. Molecular stratification of Light-Chain cardiac amyloidosis with (18)F-Florbetapir and (68)Ga-FAPI-04 for enhanced prognostic precision. JACC Cardiovasc Imaging. 2025;18(3):323\u201336.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"4040_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12350-022-02952-3","volume":"30","author":"Y Gu","year":"2023","unstructured":"Gu Y, Han K, Zhang Z, et al. (68)Ga-FAPI PET\/CT for molecular assessment of fibroblast activation in right heart in pulmonary arterial hypertension: a single-center, pilot study. J Nucl Cardiol. 2023;30(2):495\u2013503.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"4040_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-025-01592-6","volume":"25","author":"BX Chen","year":"2025","unstructured":"Chen BX, Hu H, Gong J, et al. Comparison of the value of FAPI imaging and speckle\u2011tracking echocardiography in assessment of right ventricular remodeling in pulmonary hypertension. BMC Med Imaging. 2025;25(1):68.","journal-title":"BMC Med Imaging"},{"issue":"2","key":"4040_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00259-022-05994-4","volume":"50","author":"W Song","year":"2023","unstructured":"Song W, Zhang X, He S, et al. (68)Ga-FAPI PET visualize heart failure: from mechanism to clinic. Eur J Nucl Med Mol Imaging. 2023;50(2):475\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"32","key":"4040_CR24","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37(32):4343\u201357.","journal-title":"Oncogene"},{"key":"4040_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225744","author":"T Lindner","year":"2021","unstructured":"Lindner T, Giesel FL, Kratochwil C, et al. Radioligands targeting fibroblast activation protein (FAP). Cancers. 2021;13(22):5744.","journal-title":"Cancers"},{"key":"4040_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.yjmcc.2013.11.003","volume":"70","author":"JD Lajiness","year":"2014","unstructured":"Lajiness JD, Conway SJ. Origin, development, and differentiation of cardiac fibroblasts. J Mol Cell Cardiol. 2014;70:2\u20138.","journal-title":"J Mol Cell Cardiol"},{"issue":"5","key":"4040_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.tips.2017.03.001","volume":"38","author":"Y Ma","year":"2017","unstructured":"Ma Y, Iyer RP, Jung M, et al. Cardiac fibroblast activation post-myocardial infarction: current knowledge gaps. Trends Pharmacol Sci. 2017;38(5):448\u201358.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"4040_CR28","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/cvr\/cvaa142","volume":"117","author":"S Stein","year":"2021","unstructured":"Stein S, Weber J, Nusser-Stein S, et al. Deletion of fibroblast activation protein provides atheroprotection. Cardiovasc Res. 2021;117(4):1060\u20139.","journal-title":"Cardiovasc Res"},{"key":"4040_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","volume":"87","author":"J Tillmanns","year":"2015","unstructured":"Tillmanns J, Hoffmann D, Habbaba Y, et al. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction. J Mol Cell Cardiol. 2015;87:194\u2013203.","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"4040_CR30","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","volume":"54","author":"KG Aragam","year":"2022","unstructured":"Aragam KG, Jiang T, Goel A, et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat Genet. 2022;54(12):1803\u201315.","journal-title":"Nat Genet"},{"issue":"2","key":"4040_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11307-025-01994-6","volume":"27","author":"A Hess","year":"2025","unstructured":"Hess A, Renko A, Sch\u00e4fer A, et al. Spatial FAP expression as detected by (68)\u00a0Ga-FAPI-46 identifies myofibroblasts beyond the infarct scar after reperfusion. Mol Imaging Biol. 2025;27(2):173\u201383.","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"4040_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11886-023-01869-8","volume":"25","author":"MF Mayola","year":"2023","unstructured":"Mayola MF, Thackeray JT. The potential of fibroblast activation protein-targeted imaging as a biomarker of cardiac remodeling and injury. Curr Cardiol Rep. 2023;25(6):515\u201323.","journal-title":"Curr Cardiol Rep"},{"key":"4040_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1004181","volume":"13","author":"F Zhu","year":"2022","unstructured":"Zhu F, Li P, Sheng Y. Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy. Front Pharmacol. 2022;13:1004181.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4040_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2015.01.013","volume":"21","author":"EM Mcnally","year":"2015","unstructured":"Mcnally EM, Barefield DY, Puckelwartz MJ. The genetic landscape of cardiomyopathy and its role in heart failure. Cell Metab. 2015;21(2):174\u201382.","journal-title":"Cell Metab"},{"issue":"8","key":"4040_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","volume":"58","author":"I Olivotto","year":"2011","unstructured":"Olivotto I, Girolami F, Sciagr\u00e0 R, et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol. 2011;58(8):839\u201348.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4040_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0735-1097(99)00492-1","volume":"35","author":"J Shirani","year":"2000","unstructured":"Shirani J, Pick R, Roberts WC, et al. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 2000;35(1):36\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4040_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903\u201375.","journal-title":"Eur Respir J"},{"issue":"3","key":"4040_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10741-016-9526-y","volume":"21","author":"MC Van De Veerdonk","year":"2016","unstructured":"Van De Veerdonk MC, Bogaard HJ, Voelkel NF. The right ventricle and pulmonary hypertension. Heart Fail Rev. 2016;21(3):259\u201371.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"4040_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1183\/09031936.00047712","volume":"41","author":"M Delcroix","year":"2013","unstructured":"Delcroix M, Vonk Noordegraaf A, Fadel E, et al. Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2013;41(1):224\u201332.","journal-title":"Eur Respir J"},{"issue":"1","key":"4040_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/2045893217753121","volume":"8","author":"K Asosingh","year":"2018","unstructured":"Asosingh K, Erzurum S. Mechanisms of right heart disease in pulmonary hypertension (2017 Grover Conference Series). Pulm Circ. 2018;8(1):2045893217753121.","journal-title":"Pulm Circ"},{"issue":"15","key":"4040_CR41","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","volume":"71","author":"A Gonz\u00e1lez","year":"2018","unstructured":"Gonz\u00e1lez A, Schelbert EB, D\u00edez J, et al. Myocardial interstitial fibrosis in heart failure: biological and translational perspectives. J Am Coll Cardiol. 2018;71(15):1696\u2013706.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4040_CR42","first-page":"573","volume":"15","author":"N Tamaki","year":"2025","unstructured":"Tamaki N, Aikawa T, Manabe O. (18)F-fluorodeoxyglucose imaging for assessing cardiovascular inflammation. Diagnostics (Basel, Switzerland). 2025;15(5):573.","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"2","key":"4040_CR43","first-page":"216","volume":"113","author":"L Askin","year":"2019","unstructured":"Askin L, Tanr\u0131verdi O, Tibilli H, et al. New Method Improves the Evaluation of Subclinical Left Ventricular Dysfunction in Type 2 Diabetes Mellitus. Arq Bras Cardiol. 2019;113(2):216\u20137.","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"4040_CR44","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.21037\/jtd.2018.04.141","volume":"10","author":"J Wang","year":"2018","unstructured":"Wang J, Zhao H, Wang Y, et al. Native T1 and T2 mapping by cardiovascular magnetic resonance imaging in pressure overloaded left and right heart diseases. J Thorac Dis. 2018;10(5):2968\u201375.","journal-title":"J Thorac Dis"},{"key":"4040_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.hrtlng.2025.09.007","volume":"75","author":"S Shojaei","year":"2026","unstructured":"Shojaei S, Mousavi A, Zooravar D, et al. The role of cardiac positron emission tomography in prediction of atrial fibrillation rhythm: a systematic review and meta-analysis. Heart Lung. 2026;75:125\u201335.","journal-title":"Heart Lung"},{"issue":"4","key":"4040_CR46","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s12350-021-02681-z","volume":"28","author":"AI Ahmed","year":"2021","unstructured":"Ahmed AI, Abebe AT, Han Y, et al. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: a systematic review. J Nucl Cardiol. 2021;28(4):1545\u201352.","journal-title":"J Nucl Cardiol"},{"key":"4040_CR47","first-page":"220","volume":"10(5)","author":"G Tersalvi","year":"2023","unstructured":"Tersalvi G, Beltrani V, Gr\u00fcbler MR, et al. Positron emission tomography in heart failure: from pathophysiology to clinical application. J Cardiovasc Dev Dis. 2023;10(5):220.","journal-title":"J Cardiovasc Dev Dis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-04040-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-04040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:02:30Z","timestamp":1775037750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-04040-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-04040-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval from an ethics board was not required for this study as no human or animal subjects were involved in data collection or analysis. Written informed consent was not required for this study, because we statistically analyzed other people\u2019s experiments and it was registered with PROSPERO (\n                      \n                      ) (Registration Number CRD42024561672). The scientific guarantor of this publication is Shu Wang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"485"}}